News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Artimplant Interim Report January – June 2008
August 7, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
VASTRA FROLUNDA, Sweden--(BUSINESS WIRE)--Regulatory News: • Net revenue for the second quarter amounted to SEK 3.1 million (4.7) and for the first six months to SEK 5.2 million (8.7)*
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Earnings
Gilead To Stay ‘Proactive And Disciplined’ With Deals But M&A Not Urgent Priority
February 11, 2026
·
2 min read
·
Tristan Manalac
Podcast
Weight Loss Drama Compounds on Heels of Novo, Lilly Earnings, Plus Gene Therapy News
February 11, 2026
·
1 min read
·
Jef Akst
Earnings
AstraZeneca Teases ‘Very Competitive’ Weight-Loss Pill—But Stays Mum on Details
February 10, 2026
·
2 min read
·
Tristan Manalac
Recruiting
Facing Talent Crunch, Radiopharma Field Casts a Wide Net
February 10, 2026
·
4 min read
·
Nick Paul Taylor
